Ms Leonard said: “After having achieved my goal of successfully identifying and acquiring a FDA cleared, CLIA waived product that offers CLX the opportunity to become market leader in an important healthcare sector, I am returning to my personal business of executive coaching and leadership development.
“I continue to believe that the ThyroTest product has a great future and wish CLX great success in the next steps of its launch.”